广州达安基因股份有限公司（以下简称“达安基因”）是以分子诊断技术为主导的，集临床检验试剂、仪器和配套耗材的研发、生产、销售为一体的国有生物医药高新技术企业，于2004年在深交所上市。 达安基因不但是我国核酸检测技术的开创者，而且是我国核酸检测技术产品成为代表国际前沿技术水平产品的重要贡献者。公司专注于荧光PCR诊断试剂产品的开发和应用,先后承担了30 余项国家及省部级重点攻关项目，研究成果相继获得国家科技进步奖和国家发明金奖等各类奖项。

Guangzhou Da'an gene Co., Ltd. (hereinafter referred to as ""Da'an gene"") is a state-owned biomedical high-tech enterprise focusing on molecular diagnosis technology and integrating the R & D, production and sales of clinical test reagents, instruments and supporting consumables. It was listed on the Shenzhen Stock Exchange in 2004. Daan gene is not only the pioneer of nucleic acid detection technology in China, but also an important contributor of nucleic acid detection technology products in China to represent the international advanced technology level. The company focuses on the development and application of fluorescent PCR diagnostic reagent products, and has undertaken more than 30 national and provincial key research projects. Its research achievements have won various awards such as the national science and Technology Progress Award and the National Invention Gold Award.